title: Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome.
abstract: BACKGROUND
  Ovarian reserve depends on the size and quality of oocytes stored in ovary. Aging and some diseases reduce ovarian reserve, leading to decreased reproductive performance. Laparoscopic surgery is used to treat infertility in women with PCOS. The purpose of this study was measurement of ovarian reserve in patients with PCOS before and after laparoscopic surgery.
  
  
  METHODS
  In this study thirty infertile patients with PCOS that had not responded to initial treatment with drug were selected. We assessed the serum levels of anti-mullerian hormone, testosterone, luteinizing hormone (LH), and the number of antral follicles before laparoscopic surgery and 1 week, 3 and 6 months after the surgery.
  
  
  RESULTS
  The average amount of anti-mullerian hormone serum levels was 8.4±4.7 before laparoscopic surgery and 7.5±4.5, 7±4.5, and 7.7±4.4 ng/ml one week, 3 and 6 months after surgery, respectively. Serum levels of LH was 13.6±6.7 and 12.7±11.1 IU /ml (P=0.87) before surgery and 6 months after laparoscopy, respectively. Mean serum testosterone levels were 0.9±0.8, 0.8±0.9 ng/ml (P=0.86) before and after surgery. Annual reproductive rate was 26.7 percent in this population.
  
  
  CONCLUSIONS
  Laparoscopic ovarian puncture didn't change anti-mullerian hormone serum, testosterone and LH in women with PCOS and hence has no adverse effects on the ovarian reserve.
authors.affiliation: Women Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Laya
authors.initials: L
authors.lastname: Farzadi
authors.forename: Mohammad
authors.initials: M
authors.lastname: Nouri
authors.forename: Morteza
authors.initials: M
authors.lastname: Ghojazadeh
authors.forename: Mona
authors.initials: M
authors.lastname: Mohiti
authors.forename: Esmat
authors.initials: E
authors.lastname: Aghadavod
keywords: Anti-Mullerian Hormone; Laparoscopy; Ovarian Reserve; Polycystic Ovary Syndrome